AGAMREE is indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients aged 4 years and older. Treatment with AGAMREE should only be initiated by specialist physicians with experience in the management of Duchenne muscular dystrophy

Delays Type 1 diabetes  Monoclonal antibody therapy  Prevents insulin dependence  Reduces autoimmune response

Subcutaneous injection\015\012Rozanolixizumab-noli antibody\015\012Treats generalized myasthenia gravis\015\012IgG depletion mechanism\015\012Targeted immune modulation\015\012Long-term treatment option

We are instrumental in trading a qualitative range of Pharmaceutical Injection including Agamree Vamorolone 40mg ml Injection, Tzield 2mg injection, RYSTIGGO Rozanolixizumab-noli Injection etc.

APRICOT LABS PRIVATE LIMITED - Manufacturer of Pharmaceutical Injection, from Hyderabad, Telangana, India.

Apricot Labs Private Limited - Pharmaceutical Injection (3)

All Categories

Agamree Vamorolone 40mg ml Injection

Tzield 2mg injection

RYSTIGGO Rozanolixizumab-noli Injection